Providing Quality Retinal Care for 35 Years

Scott Pautler, MD
Dr. Pautler graduated with high honors from the University of Florida where he was inducted into Phi Eta Sigma honor society. He obtained his retina training at the prestigious Bascom Palmer Eye Institute at the University of Miami. He continues to participate in clinical research and is a Clinical Associate Professor at the University of South Florida. He has been named 3 times in the listing of Best Doctors of America. MORE
Steven Cohen, MD
Dr. Cohen graduated with honors from Harvard College in Mathematics and completed his medical training at Harvard Medical School.  He completed two years of Retina fellowship training at the Bascom Palmer Eye Institute at the University of Miami.  He is a Clinical Professor of Ophthalmology at the University of South Florida and a Fellow of the American Academy of Ophthalmology.  MORE
Karina Billiris-Findlay, MD
Dr. Billiris Findlay has been practicing retina since 1997. She graduated Summa Cum Laude from the University of South Florida in Chemistry. She completed her medical training and Ophthalmology Residency at USF and her Retina Fellowship with Retina-Vitreous Associates of Florida. She is a member of the Alpha Omega Alpha medical honor society, a Fellow of the American College of Surgeons and a Clinical Assistant Professor of Ophthalmology. MORE
David Eichenbaum, MD
Dr. Eichenbaum is a board certified ophthalmologist specializing in diseases and surgery of the vitreous and retina.  He earned his medical degree at the University of South Florida in Tampa and completed his ophthalmology residency at the University of South Florida. Dr. Eichenbaum completed his two year vitreo-retinal fellowship at Tufts University in Boston.  He has published in several professional journals and textbook chapters. MORE

Tampa Bay Florida

Retina News

Medicare has issued a local policy decision allowing for Avastin coverage for many retinal vascular diseases and for macular edema.  This is great news because Avastin is helpful for patients with macular edema and retinal vein occlusion or diabetic retinopathy, especially those who have glaucoma making intravitreal Kenalog a little risky.

Neovascular Regression and Improved Visual Acuity Achieved With Combined Anti-PDGF/Anti-VEGF Therapy

Results from a phase 1 clinical study showed that E10030 (Ophthotech Corporation) produced significant neovascular regression and enhanced visual outcomes in patients with wet age-related macular degeneration (AMD). The results were presented at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting in Fort Lauderdale, FL. ...

Pattern Laser Treatment Less Painful Than Conventional, Surgeon Reports

Pattern scanning laser treatment appears to be less painful and is shorter in duration compared with conventional laser therapy, according to Jan E.E. Keunen, MD, from UMC Radboud in Nijmegen, Netherlands. Dr. Keunen presented the results of a pilot study that tested the pain levels experienced by patients undergoing conventional laser treatment vs...

DR Progression Software Available in Europe

Critical Health, SA (Coimbra, Portugal) launched RetmarkerDR, a diabetic retinopathy (DR) progression biomarker software for the European market, at the Euretina Congress. The solution is based on microaneurysm turnover, a biomarker of DR progression. RetmarkerDR, which can be used to capture the microaneurysm turnover in the initial stages of the ...